首页> 外文期刊>World Journal of Gastroenterology >Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option
【24h】

Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option

机译:射频消融治疗脾功能亢进:可行的治疗选择

获取原文
           

摘要

We present a case of a patient with hypersplenism secondary to portal hypertension due to hepato-splenic schistosomiasis, which was accompanied by severe and refractory thrombocytopenia. We performed spleen ablation and measured the total spleen and ablated volumes with contrast-enhanced computed tomography and volumetry. No major complications occurred, thrombocytopenia was resolved, and platelet levels remained stable, which allowed for early treatment of the patient’s underlying disease. Previous work has shown that splenic radiofrequency ablation is an attractive alternative treatment for hypersplenism induced by liver cirrhosis. We aimed to contribute to the currently sparse literature evaluating the role of radiofrequency ablation (RFA) in the management of hypersplenism. We conclude that splenic RFA appears to be a viable and promising option for the treatment of hypersplenism.
机译:我们提出了一例因肝脾血吸虫病继发于门静脉高压症的脾功能亢进患者,并伴有严重和难治性血小板减少症。我们进行了脾切除术,并通过对比增强的计算机断层扫描和容积法测量了总的脾和切除的体积。没有发生重大并发症,血小板减少症得以解决,血小板水平保持稳定,从而可以早期治疗患者的基础疾病。先前的研究表明,脾射频消融术是治疗肝硬化引起的脾功能亢进的一种有吸引力的替代疗法。我们旨在为评估射频消融(RFA)在脾功能亢进管理中的作用的当前稀疏文献做出贡献。我们得出结论,脾RFA似乎是治疗脾功能亢进的可行且有前途的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号